Home » Newsletters » BioWorld Science

BioWorld Science

March 1, 2000

View Archived Issues

Cytoclonal isolates new class of genes involved in paclitaxel synthesis

Thai Remune study results reported

Progen uses Australian placement to advance development of PI-88

Cellegy advances transdermal therapies

Role of dietary factors discussed at cardiovascular disease conference

Maxia presents preclinical data for novel insulin sensitizer

GVAX lung cancer vaccine advances to multicenter phase I/II trials

Company Profile: Novirio

Rotamase inhibitors developed at Agouron for neurological disorders

Fujisawa presents new imidazoles with inhibitory activity against adenosine deaminase

New Zambon macrolide with prolonged therapeutic efficacy

Merck patents new series of cytokine inhibitors with imidazole structure

Agents for MTP- and ApoB-dependent conditions presented by Novartis scientists

Deuteroporphyrin-based MRI contrast agents designed at Schering

Ono-2506 has protective and therapeutic efficacy in EAN

Fujisawa backs Adherex and its novel cancer therapeutic

Celgene accelerates development of second-generation compounds from the thalidomide class

Phase I results support further evaluation of i.v. R-101933 + paclitaxel

Periostat receives U.K. marketing approval for treatment of chronic adult periodontitis

FDA approves new Allegra formulations

Santen seeks FDA approval of levofloxacin for bacterial conjunctivitis

RCT forms new bioventure to support biomedical, life sciences discoveries in U.K. and Ireland

Agents for the treatment, prevention and diagnosis of bone disease available for licensing from Salk

Alimta, a multitargeted antifolate: clinical experience outlined at ICACT

AstraZeneca files sNDA with FDA for Casodex 150 mg

Nabi-NicVAX attenuates nicotine dependence in rats

NK1 receptor antagonist and prodrug thereof for treatment of emesis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...